Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs
Lnk/Sh2b3 Regulates Adipose Inflammation and Glucose Tolerance through Group 1 ILCs
复制标题
DOI:
10.1016/j.celrep.2018.07.036
复制
发表时间:
2018-08-14
期刊:
影响因子:
8.8
通讯作者:
Takaki, Satoshi
中科院分区:
文献类型:
--
作者:
Mori, Taizo;Suzuki-Yamazaki, Nao;Takaki, Satoshi
Lnk/Sh2b3 is an adaptor protein that negatively regulates cytokine signaling in lymphohematopoiesis. A missense variant within the LNK/SH2B3 gene has been reported to be a risk variant for several autoimmune diseases, including diabetes. We found that glucose tolerance and insulin responses were impaired in Lnk(-/)(-) mice. Moreover, immune cells such as group 1 innate lymphoid cells (G1-ILCs), CD8(+) T cells, and M1 macrophages accumulated in adipose tissue. When Lnk(-/)(-) mice were crossed with Il15(-/- )mice or depleted of G1-ILCs but not CD8(+) T cells, glucose intolerance and adipose inflammation were ameliorated. Lnk(-/)(-) G1-ILCs showed activated phenotypes as well as enhanced reactivity for IL-15, and administration of a JAK inhibitor improved glucose tolerance. Accordingly, a high-fat diet greatly worsened glucose intolerance in Lnk(-/)(-) mice. Thus, Lnk/Sh2b3 controls homeostasis in adipose tissue and reduces the risk of onset of diabetes by regulating the expansion and activation of IL-15-dependent adipose G1-ILCs.